StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a note issued to investors on Tuesday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of ENZ stock opened at $0.48 on Tuesday. The firm has a 50-day moving average price of $0.72 and a 200 day moving average price of $0.97. Enzo Biochem has a twelve month low of $0.41 and a twelve month high of $1.40.

Enzo Biochem (NYSE:ENZ) last posted its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Hedge Funds Weigh In On Enzo Biochem

A number of institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC raised its position in shares of Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares in the last quarter. Lepercq Multi Asset Fund purchased a new stake in shares of Enzo Biochem during the fourth quarter valued at $88,000. BBR Partners LLC purchased a new stake in Enzo Biochem in the 3rd quarter worth about $112,000. Finally, Virtu Financial LLC purchased a new stake in shares of Enzo Biochem during the 4th quarter worth about $35,000. 36.90% of the stock is owned by institutional investors and hedge funds.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.